Contract research organisation INC Research has expended the consulting side of its business with the launch of a new strategic advisory services unit.
Led by INC’s senior vice president of global consulting and strategic alliances Tim Dietlin, the new unit will cover both drug development and products’ subsequent commercialisation with the aim of spanning the entire product lifecycle.
“Working as an integrated team gives our expert advisors better visibility into our customers’ product development lifecycles and needs, enabling a true strategic partnership to evolve,” Dietlin said.
“This model allows greater flexibility and agility to identify opportunities, anticipate challenges and offer a broader range of perspectives and options for how to best address them.”
The new unit will also offer regulatory consulting and submissions, and quality assurance services and will be made up of three practice areas. These will be strategic management consulting division AVOS consulting, regulatory consulting and submissions, and compliance consulting.